Alpha 2.0
Login Register
» Articles » PMID: 33361254

Alzheimer Disease Spectrum: Syndrome and Etiology From Clinical and PET Imaging Perspectives

Overview
Journal Neurology
Specialty Neurology
Date 2020 Dec 28
PMID 33361254
Citations 5
Authors
David S Knopman
William J Jagust
Affiliations
Soon will be listed here.
Citing Articles

Morphometric and Nanomechanical Screening of Peripheral Blood Cells with Atomic Force Microscopy for Label-Free Assessment of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.

Taneva S, Todinova S, Andreeva T Int J Mol Sci. 2023; 24(18).

PMID: 37762599 PMC: 10531602. DOI: 10.3390/ijms241814296.

The Pursuit of the "Inside" of the Amyloid Hypothesis-Is C99 a Promising Therapeutic Target for Alzheimer's Disease?.

Takasugi N, Komai M, Kaneshiro N, Ikeda A, Kamikubo Y, Uehara T Cells. 2023; 12(3).

PMID: 36766796 PMC: 9914381. DOI: 10.3390/cells12030454.

Mitochondrial proteotoxicity: implications and ubiquitin-dependent quality control mechanisms.

Karbowski M, Oshima Y, Verhoeven N Cell Mol Life Sci. 2022; 79(11):574.

PMID: 36308570 PMC: 11803029. DOI: 10.1007/s00018-022-04604-8.

Electroacupuncture Improves Clearance of Amyloid- through the Glymphatic System in the SAMP8 Mouse Model of Alzheimer's Disease.

Liang P, Li L, Zhang Y, Shen Y, Zhang L, Zhou J Neural Plast. 2021; 2021:9960304.

PMID: 34484327 PMC: 8416373. DOI: 10.1155/2021/9960304.

News about the Role of Fluid and Imaging Biomarkers in Neurodegenerative Diseases.

Meldolesi J Biomedicines. 2021; 9(3).

PMID: 33806691 PMC: 7999537. DOI: 10.3390/biomedicines9030252.

References
1.
Jack Jr C, Wiste H, Weigand S, Therneau T, Knopman D, Lowe V . Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study. Lancet Neurol. 2017; 16(6):435-444. PMC: 5516534. DOI: 10.1016/S1474-4422(17)30077-7. View
2.
Villemagne V, Burnham S, Bourgeat P, Brown B, Ellis K, Salvado O . Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol. 2013; 12(4):357-67. DOI: 10.1016/S1474-4422(13)70044-9. View
3.
Therriault J, Pascoal T, Benedet A, Tissot C, Savard M, Chamoun M . Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, ε4, and Cognitive Impairment. Neurology. 2021; 96(7):e975-e985. PMC: 8055338. DOI: 10.1212/WNL.0000000000011416. View
4.
Fleisher A, Pontecorvo M, Devous Sr M, Lu M, Arora A, Truocchio S . Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes. JAMA Neurol. 2020; 77(7):829-839. PMC: 7186920. DOI: 10.1001/jamaneurol.2020.0528. View
5.
Petersen R, Roberts R, Knopman D, Boeve B, Geda Y, Ivnik R . Mild cognitive impairment: ten years later. Arch Neurol. 2009; 66(12):1447-55. PMC: 3081688. DOI: 10.1001/archneurol.2009.266. View